Semen Analysis in "Urology-Naïve" Patients: A Chance of Uroandrological Screening in Young Males.
EcoFoodFertility project
infertility
pollution
screening
semen analysis
young male patients
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
01 Jun 2023
01 Jun 2023
Historique:
received:
21
03
2023
revised:
11
05
2023
accepted:
25
05
2023
medline:
10
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
(1) Background: While females start their gynecological examinations during puberty, only few men decide to be visited by urologists in their youth. Given the participation in the EcoFoodFertility research project, our department had the opportunity to screen young males that were supposedly healthy. (2) Results: from January 2019 to July 2020, we evaluated 157 patients with sperm, blood analysis, and uroandrological examinations. The inclusion criteria were age 18-40 and absence of previous urological disease (urology-naïve). The primary endpoint of the study was to record uroandrological diseases that are occasionally discovered during examination in asymptomatic young men. The average age was 26.9 years (range 18-40); average testicular volume was 15.7 mL (range 12-22 mL); and 45.2% reported abnormal semen analysis: 62 cases of teratozoospermia, 27 asthenozoospermia, 18 oligozoospermia, and 2 azoospermia were discovered respectively; 4/157 patients were diagnosed with hypogonadism; 2 cases with suspicious testicular mass resulted in testicular cancer; and 31 suspected varicoceles and 8 patients with mild sexual dysfunctions were managed. (3) Conclusions: an uroandrological evaluation of young asymptomatic males allowed for the prompt diagnosis of different urological conditions, including cancerous ones, in our series. Despite being debatable, combining urological counselling with physical examination, semen analysis, and a laboratory profile could be useful and cost-effective in order to ameliorate male health.
Identifiants
pubmed: 37298000
pii: jcm12113803
doi: 10.3390/jcm12113803
pmc: PMC10253905
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Asian J Androl. 2016 Mar-Apr;18(2):179-81
pubmed: 26763551
HRB Open Res. 2018 May 14;1:16
pubmed: 32002508
Arch Ital Urol Androl. 2020 Dec 21;92(4):
pubmed: 33348967
Int J Environ Res Public Health. 2022 Sep 15;19(18):
pubmed: 36141930
Andrology. 2021 Mar;9(2):503-510
pubmed: 33251770
Eur Urol. 2011 Oct;60(4):796-808
pubmed: 21733620
Fertil Steril. 2020 Mar;113(3):469-477
pubmed: 32089256
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Hum Reprod Update. 2017 Nov 1;23(6):646-659
pubmed: 28981654
Int J Mol Sci. 2017 Aug 04;18(8):
pubmed: 28777293
Med Clin North Am. 2018 Mar;102(2):251-264
pubmed: 29406056
Hum Reprod Update. 2019 Sep 11;25(5):518-540
pubmed: 31374565
Behav Sci (Basel). 2016 Aug 05;6(3):
pubmed: 27527226
Cancer Epidemiol. 2018 Oct;56:106-111
pubmed: 30130682
J Sex Med. 2013 Jul;10(7):1833-41
pubmed: 23651423
BJU Int. 2019 Jun;123(6):1070-1077
pubmed: 30328251
Hum Reprod Update. 2010 May-Jun;16(3):231-45
pubmed: 19934213
Am J Mens Health. 2017 Jul;11(4):1279-1304
pubmed: 27099345
Reprod Toxicol. 2016 Dec;66:1-9
pubmed: 27592743
Urology. 2014 Aug;84(2):450-5
pubmed: 24928462
Transl Androl Urol. 2017 Feb;6(1):79-90
pubmed: 28217453
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):501-5
pubmed: 16005920
Reprod Biol Endocrinol. 2015 Apr 26;13:37
pubmed: 25928197
Int J Endocrinol. 2012;2012:649149
pubmed: 22319527
Eur Urol Focus. 2020 Jan 15;6(1):178-183
pubmed: 30082228
Aging (Albany NY). 2019 Dec 2;11(23):10952-10991
pubmed: 31790362
Eur Urol Focus. 2022 Jan;8(1):351-359
pubmed: 33579652
Eur Urol. 2017 Jan;71(1):46-52
pubmed: 27084245
Fertil Steril. 2020 Nov;114(5):984-996
pubmed: 32709378
Asian J Androl. 2017 Mar-Apr;19(2):219-222
pubmed: 26806083
Int J Mol Sci. 2022 Jan 29;23(3):
pubmed: 35163492